AFP Peptide (PLFQVPEPV)
Alpha-1-Fetoprotein (AFP) is a human glycoprotein with various implications in the human carcinogenesis process. As such, it is frequently investigated in the context of tumor therapy development.
Showing 97–112 of 281 results
-
-
Antigen Peptide Capsid protein H2-Ld (VPQYGYLTL)
Antigen Peptide Capsid protein H2-Ld (VPQYGYLTL)
-
Atrial Natriuretic Peptide (ANP) (1-28), human, porcine
Atrial natriuretic peptide (ANP), a stimulator of particulate guanylate cyclase, has been found to protect against reoxygenation-induced hypercontracture in isolated cardiomyocytes by increasing cyclic guanosine monophosphate synthesis; ANP also contributes to stimulation of lipolysis during repeated bouts of exercise and in the control of lipolysis during exercise.
-
Biotin-β-Amyloid (1-40)
β-Amyloid (1-40) is a primary protein in plaques found in the brains of patients with Alzheimer’s disease. It is the major component of senile plaque amyloids, are physiological peptides present in the brain, cerebrospinal fluid (CSF) and plasma.This peptide is biotinylated at its N-terminu. Biotin is widely used throughout the biotechnology industry to conjugate proteins for biochemical assays. Biotin can be used for qualitative and quantitative detection, labelling or immobilisation.
-
Biotin-β-Amyloid (1-42), human
Aß (1-42), a major component of amyloid plaques, accumulates in neurons of Alzheimer’s disease brains. Biochemical analysis of the amyloid peptides isolated from Alzheimer’s disease brain indicates that Aß (1-42) is the principal species associated with senile plaque amyloids, while Aß (1-40) is more abundant in cerebrovascular amyloid deposit.
This peptide is biotinylated at the N-terminus for convenient detection and purification. -
c-Myc Peptide
c-Myc Peptide is a useful for displacement of c-Myc-tagged fusion proteins bound to anti-c-Myc antibodies in immunoassays. The successful inhibition of antibody binding by c-Myc peptide demonstrates binding is specific. c-Myc Peptide participates in regulation of growth-related gene transcription.
-
C-Peptide (3-33), human
C-Peptide is a byproduct of insulin production, usually by the pancreas. The level of C-peptide can be used as a gauge of how much insulin is being produced in the body. The amount of C-peptide in the blood can indicate the presence or absence of disease. Abnormally low amounts of C-peptide in the blood suggest that insulin production is too low or absent because of type I diabetes, also known as juvenile or insulin-dependent diabetes. Abnormally high amounts of C-peptide warn of the possible presence of insulinoma tumors, which secrete insulin.
-
C-Type Natriuretic Peptide (CNP) (1-22), human
C-type natriuretic peptide is produced in the hypothalamus, anterior pituitary, and most major endocrine glands. C-type natriuretic peptide has potent venodilatory and coronary vasodilatory effects, but minimal effects on renal function.
-
Calcitonin Gene Related Peptide (CGRP) (8-37), rat
Calcitonin Gene Related Peptide (CGRP)(8-37) inhibits the evoked discharge frequency of wide dynamic range neurons in dorsal horn of the spinal cord in rats. The present study was performed to explore the effect of CGRP(8-37) on the electrical stimulation-evoked discharge frequency of wide dynamic range (WDR) neurons in the dorsal horn of the spinal cord in rats. The results indicate that CGRP receptors play an important role in the transmission of presumed nociceptive information in the dorsal horn of the spinal cord.
-
Calcitonin Gene Related Peptide (CGRP), rat
Calcitonin Gene Related Peptide (rat) is a potent, long-lasting vasodilator; activation of CGRP receptors on pancreatic β-cells increases plasma levels of pancreatic enzymes.
-
CEF control peptide pool
The CEF Control Peptide Pool is a group of 32 peptides, 8-12 amino acids in length, with sequences derived from the human Cytomegalovirus, Epstein-Barr Virus and Influenza Virus. RP30239-1 contains 0.03 mg of the 32 CEF peptides for a total of 1 mg in one vial. RP30239-2 contains 0.06 mg of the 32 CEF peptides for a total of 2 mg in one vial. Used in the stimulation of IFNg release from CD8+ T cells in individuals with defined HLA types, these epitopes are useful in applications such as ELISPOT, intracellular cytokine and CTL assays.
-
-
-
-
-